Toward a Network Model of MHC Class II-Restricted Antigen Processing

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2014 Jan 1

PMID 24379819

Citations 9

Authors

Michael A Miller

Asha Purnima V Ganesan

Laurence C Eisenlohr

Affiliations

Soon will be listed here.

Abstract

The standard model of Major Histocompatibility Complex class II (MHCII)-restricted antigen processing depicts a straightforward, linear pathway: internalized antigens are converted into peptides that load in a chaperone dependent manner onto nascent MHCII in the late endosome, the complexes subsequently trafficking to the cell surface for recognition by CD4(+) T cells (TCD4+). Several variations on this theme, both moderate and radical, have come to light but these alternatives have remained peripheral, the conventional pathway generally presumed to be the primary driver of TCD4+ responses. Here we continue to press for the conceptual repositioning of these alternatives toward the center while proposing that MHCII processing be thought of less in terms of discrete pathways and more in terms of a network whose major and minor conduits are variable depending upon many factors, including the epitope, the nature of the antigen, the source of the antigen, and the identity of the antigen-presenting cell.

Citing Articles

Flublok Quadrivalent Vaccine Adjuvanted with R-DOTAP Elicits a Robust and Multifunctional CD4 T Cell Response That Is of Greater Magnitude and Functional Diversity Than Conventional Adjuvant Systems.

White C, Glover M, Gandhapudi S, Richards K, Sant A Vaccines (Basel). 2024; 12(3).

PMID: 38543915 PMC: 10975948. DOI: 10.3390/vaccines12030281.

HIV-1-Infected CD4 T Cells Present MHC Class II-Restricted Epitope via Endogenous Processing.

Addison M, Ellis G, Leslie G, Zawadzky N, Riley J, Hoxie J J Immunol. 2022; 209(5):864-873.

PMID: 36130133 PMC: 9512365. DOI: 10.4049/jimmunol.2200145.

Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation.

Toulmin S, Bhadiadra C, Paris A, Lin J, Katzen J, Basil M Nat Commun. 2021; 12(1):3993.

PMID: 34183650 PMC: 8239023. DOI: 10.1038/s41467-021-23619-6.

HLA-Class II Artificial Antigen Presenting Cells in CD4 T Cell-Based Immunotherapy.

Couture A, Garnier A, Docagne F, Boyer O, Vivien D, Le-Mauff B Front Immunol. 2019; 10:1081.

PMID: 31156634 PMC: 6533590. DOI: 10.3389/fimmu.2019.01081.

Poor Antigen Processing of Poxvirus Particles Limits CD4 T Cell Recognition and Impacts Immunogenicity of the Inactivated Vaccine.

Forsyth K, DeHaven B, Mendonca M, Paul S, Sette A, Eisenlohr L J Immunol. 2019; 202(5):1340-1349.

PMID: 30700590 PMC: 6394857. DOI: 10.4049/jimmunol.1801099.

References

Pos W, Sethi D, Call M, Schulze M, Anders A, Pyrdol J . Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection. Cell. 2012; 151(7):1557-68. PMC: 3530167. DOI: 10.1016/j.cell.2012.11.025. View

Hampl J, Gradehandt G, Kalbacher H, Rude E . In vitro processing of insulin for recognition by murine T cells results in the generation of A chains with free CysSH. J Immunol. 1992; 148(9):2664-71. View

Zhou F . Molecular mechanisms of viral immune evasion proteins to inhibit MHC class I antigen processing and presentation. Int Rev Immunol. 2009; 28(5):376-93. DOI: 10.1080/08830180903013034. View

Morrison L, Lukacher A, Braciale V, Fan D, Braciale T . Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J Exp Med. 1986; 163(4):903-21. PMC: 2188068. DOI: 10.1084/jem.163.4.903. View

van Noort J, Boon J, Van der Drift A, WAGENAAR J, Boots A, Boog C . Antigen processing by endosomal proteases determines which sites of sperm-whale myoglobin are eventually recognized by T cells. Eur J Immunol. 1991; 21(9):1989-96. DOI: 10.1002/eji.1830210904. View

Germain R . A role for peptide in determining MHC class II structure. Nature. 1991; 353(6340):167-70. DOI: 10.1038/353167a0. View

Tulp A, Verwoerd D, Dobberstein B, Ploegh H, Pieters J . Isolation and characterization of the intracellular MHC class II compartment. Nature. 1994; 369(6476):120-6. DOI: 10.1038/369120a0. View

Kantor F, Ojeda A, BENCARERRAF B . Studies on artifical antigens. I. Antigenicity of DNP-polylysine and DNP copolymer of lysine and glutamic acid in guinea pigs. J Exp Med. 1963; 117:55-69. PMC: 2180431. DOI: 10.1084/jem.117.1.55. View

Cresswell P . Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol. 1994; 12:259-93. DOI: 10.1146/annurev.iy.12.040194.001355. View

10.

Roche P, Marks M, Cresswell P . Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature. 1991; 354(6352):392-4. DOI: 10.1038/354392a0. View

11.

Peters P, Raposo G, Neefjes J, Oorschot V, Leijendekker R, Geuze H . Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes. J Exp Med. 1995; 182(2):325-34. PMC: 2192145. DOI: 10.1084/jem.182.2.325. View

12.

Yewdell J, Bennink J, Hosaka Y . Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science. 1988; 239(4840):637-40. DOI: 10.1126/science.3257585. View

13.

ZIEGLER H, UNANUE E . Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A. 1982; 79(1):175-8. PMC: 345685. DOI: 10.1073/pnas.79.1.175. View

14.

Sanderson F, Kleijmeer M, Kelly A, Verwoerd D, Tulp A, Neefjes J . Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science. 1994; 266(5190):1566-9. DOI: 10.1126/science.7985027. View

15.

Rabinowitz J, Vrljic M, Kasson P, Liang M, Busch R, Boniface J . Formation of a highly peptide-receptive state of class II MHC. Immunity. 1998; 9(5):699-709. DOI: 10.1016/s1074-7613(00)80667-6. View

16.

Pereira S, Faca V, Gomes G, Chammas R, Maria Fontes A, Covas D . Changes in the proteomic profile during differentiation and maturation of human monocyte-derived dendritic cells stimulated with granulocyte macrophage colony stimulating factor/interleukin-4 and lipopolysaccharide. Proteomics. 2005; 5(5):1186-98. DOI: 10.1002/pmic.200400988. View

17.

Yeager M, Carrington M, Hughes A . Class I and class II MHC bind self peptide sets that are strikingly different in their evolutionary characteristics. Immunogenetics. 2000; 51(1):8-15. DOI: 10.1007/s002510050002. View

18.

Lennon-Dumenil A, Bakker A, Ploegh H, Lagaudriere-Gesbert C . A closer look at proteolysis and MHC-class-II-restricted antigen presentation. Curr Opin Immunol. 2002; 14(1):15-21. DOI: 10.1016/s0952-7915(01)00293-x. View

19.

Wilkinson T, Li C, Chui C, Huang A, Perkins M, Liebner J . Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012; 18(2):274-80. DOI: 10.1038/nm.2612. View

20.

Eisenlohr L, Hackett C . Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis. J Exp Med. 1989; 169(3):921-31. PMC: 2189282. DOI: 10.1084/jem.169.3.921. View